indibulin
Sponsors
Alaunos Therapeutics
Conditions
Advanced CancerAdvanced Solid TumorsMetastatic Breast CancerSolid Tumors
Phase 1
Phase I Study of Indibulin in Patients With Solid Tumors
CompletedNCT00591136
Start: 2003-04-30End: 2008-09-30Updated: 2012-07-19
Phase I Study in Advanced Solid Tumors
NCT00591292
Start: 2007-06-30End: 2013-06-30Updated: 2012-07-19
Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans
CompletedNCT00591890
Start: 2007-10-31End: 2009-03-31Updated: 2012-07-19
Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors
NCT00591383
Start: 2008-01-31End: 2013-06-30Updated: 2012-07-19
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors
NCT00726687
Start: 2008-06-30End: 2013-06-30Updated: 2012-07-19
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
NCT01113970
Start: 2010-03-31End: 2013-05-31Target: 60Updated: 2013-01-30